A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Purpose Benzodiazepines are effective medicines for insomnia and anxiety but are commonly used beyond recommended treatment time frames, which may lead to adverse drug events. The aim of this systematic review was to critically evaluate the success of interventions used to reduce benzodiazepines and 'Z-drug' use, and the impact of these interventions on clinical outcomes in older adults. Methods A search was conducted in PubMed, Embase, Informit, International Pharmaceutical Abstracts, Scopus, PsychINFO, Cochrane Central Register of Controlled Trials (CENTRAL) and CINAHL. Studies conducted in older adults (≥65 years) and published between January 1995 and July 2015 were included. Two authors independently reviewed all articles for eligibility and extracted the data. Results Seven studies of benzodiazepines and Z-drug withdrawal were identified. Benzodiazepine discontinuation rates were 64.3% in one study that employed pharmacological substitution with melatonin and 65.0% in a study that employed general practitioner-targeted intervention. Mixed interventions including patient education and tapering (n = 2), pharmacological substitution with psychological support (n = 1) and tapering with psychological support (n = 1) yielded discontinuation rates between 27.0 and 80.0%. Five studies measured clinical outcomes following benzodiazepine discontinuation. Most (n = 4) observed no difference in prevalence of withdrawal symptoms or sleep quality, while one study reported decline in…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the elderly, long-term use of BZDs increases the risk of falls and hip fractures, road accidents, cognitive decline, and mortality [32,33,34].”
From Cognitive behavioral therapy and acceptance and commitment therapy for the discontinuation of long-term benzodiazepine use in insomnia and anxiety disorders (2021) · cites this paper as [32]
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010) · International Journal of Surgery · doi:10.1016/j.ijsu.2010.02.007 · Cited by 12,156
Reeve, E., Gnjidic, D., Long, J., & Hilmer, S. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12732 · Cited by 855
Self-citationBenzodiazepine Use in the United States
Olfson, M., King, M., & Schoenbaum, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1763 · Cited by 786
Tannenbaum, C., Martin, P., Tamblyn, R., Benedetti, A., & Ahmed, S. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.949 · Cited by 665
Benzodiazepines revisited—will we ever learn?
Lader, M. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03563.x · Cited by 573
Benzodiazepine use and risk of Alzheimer's disease: case-control study
Billioti de Gage, S., Moride, Y., Ducruet, T., Kurth, T., Verdoux, H., Tournier, M., Pariente, A., & Begaud, B. (2014) · BMJ · doi:10.1136/bmj.g5205 · Cited by 558
Benzodiazepines and Risk of Hip Fractures in Older People: A Review of the Evidence
Cumming, R. G., & Le Couteur, D. G. (2003) · CNS Drugs · doi:10.2165/00023210-200317110-00004 · Cited by 332
Rossi, S. (2012) · doi:10.1081/e-ecp-120006366 · Cited by 287
Management of benzodiazepine misuse and dependence
Brett, J., & Murnion, B. (2015) · Australian Prescriber · doi:10.18773/austprescr.2015.055 · Cited by 260
Trends in psychotropic medication use among U.S. adults
Paulose‐Ram, R., Safran, M. A., Jonas, B. S., Gu, Q., & Orwig, D. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1367 · Cited by 215
CURRAN, H. V., COLLINS, R., FLETCHER, S., KEE, S. C. Y., WOODS, B., & ILIFFE, S. (2003) · Psychological Medicine · doi:10.1017/s0033291703008213 · Cited by 190
Usage of benzodiazepines: A review
Donoghue, J., & Lader, M. (2010) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651500903447810 · Cited by 156
Gould, R. L., Coulson, M. C., Patel, N., Highton-Williamson, E., & Howard, R. J. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.126003 · Cited by 156
Long-term benzodiazepine use by elderly people living in the community
Jorm, A. F., Grayson, D., Creasey, H., Waite, L., & Broe, G. A. (2000) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1467-842x.2000.tb00715.x · Cited by 129
Siriwardena, A. N., Qureshi, Z., Gibson, S., Collier, S., & Latham, M. (2006) · PubMed Central · Cited by 118
Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents
Salzman, C., Fisher, J., Nobel, K., Glassman, R., Wolfson, A., & Kelley, M. (1992) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930070205 · Cited by 117
Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review
Pollmann, A. S., Murphy, A. L., Bergman, J. C., & Gardner, D. M. (2015) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-015-0019-8 · Cited by 114
The benefits and harms of deprescribing
Reeve, E., Shakib, S., Hendrix, I., Roberts, M. S., & Wiese, M. D. (2014) · Medical Journal of Australia · doi:10.5694/mja13.00200 · Cited by 113
Self-citationProblems and Pitfalls in the Use of Benzodiazepines in the Elderly
Kruse, W. (1990) · Drug Safety · doi:10.2165/00002018-199005050-00003 · Cited by 110
Garzón, C. E. R., Guerrero, J. M., Aramburu, Ó., & Guzmán, T. (2009) · Aging Clinical and Experimental Research · doi:10.1007/bf03324897 · Cited by 106
Westbury, J., Jackson, S., Gee, P., & Peterson, G. (2010) · International Psychogeriatrics · doi:10.1017/s1041610209991128 · Cited by 92
Defining Patterns of Benzodiazepine Use in Older Adults
Llorente, M. D., David, D., Golden, A. G., & Silverman, M. A. (2000) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198870001300309 · Cited by 77
Twenty‐year trends in benzodiazepine dispensing in the Australian population
Islam, M. M., Conigrave, K. M., Day, C. A., Nguyen, Y., & Haber, P. S. (2014) · Internal Medicine Journal · doi:10.1111/imj.12315 · Cited by 73
Benzodiazepine prescribing in elderly Australian general practice patients
Windle, A., Elliot, E., Duszynski, K. M., & Moore, V. (2007) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1753-6405.2007.00091.x · Cited by 71
Le Couteur, D., Banks, E., Gnjidic, D., & McLachlan, A. (2011) · Australian Prescriber · doi:10.18773/austprescr.2011.095 · Cited by 60
Self-citationSalonoja, M., Salminen, M., Aarnio, P., Vahlberg, T., & Kivela, S. L. (2010) · Age and Ageing · doi:10.1093/ageing/afp255 · Cited by 59
Alvarenga, J. M., Filho, A. I. D. L., Firmo, J. O. A., Lima‐Costa, M. F., & Uchôa, E. (2007) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462006005000062 · Cited by 55
Gnjidic, D., Couteur, D. G. L., & Hilmer, S. N. (2014) · BMJ · doi:10.1136/bmj.g7013 · Cited by 51
Self-citationComparing patterns of long‐term benzodiazepine use between a Dutch and a Swedish community
van Hulten, R., Isacson, D., Bakker, A., & Leufkens, H. G. (2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.784 · Cited by 50
Feasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study
Bourgeois, J., Elseviers, M. M., Bortel, L. M. V., Petrović, M., & Stichele, R. V. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-014-1725-7 · Cited by 44
Petrovic, M., Pevernagie, D., Mariman, A., Van Maele, G., & Afschrift, M. (2002) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-001-0387-4 · Cited by 42
Martin, P., Tamblyn, R. M., Ahmed, S., Benedetti, A., & Tannenbaum, C. (2015) · Trials · doi:10.1186/s13063-015-0791-1 · Cited by 39
Smith, A. J., & Tett, S. (2009) · Drugs & Aging · doi:10.2165/0002512-200926020-00003 · Cited by 39
Perceptions of German GPs on benefits and risks of benzodiazepines and Z-drugs
Hoffmann, F. (2013) · Swiss Medical Weekly · doi:10.4414/smw.2013.13745 · Cited by 39
Deprescribing: a brave new word?
Alldred, D. P. (2014) · International Journal of Pharmacy Practice · doi:10.1111/ijpp.12093 · Cited by 36
Benzodiazepine use and risk of Alzheimers disease: case-control study
de Gage, S. B., Moride, Y., & Ducruet, T. (2014) · Dialnet (Universidad de la Rioja) · Cited by 32
Psycholeptic use in aged care homes in Tasmania, Australia
Westbury, J. L., Jackson, S., & Peterson, G. M. (2009) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2009.01079.x · Cited by 28
Analysis of benzodiazepine withdrawal program managed by primary care nurses in Spain
Lopez-Peig, C., Mundet, X., Casabella, B., del Val, J. L., Lacasta, D., & Diogene, E. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-684 · Cited by 25
Benzodiazepines and risk of Alzheimer's disease
Yaffe, K., & Boustani, M. (2014) · BMJ · doi:10.1136/bmj.g5312 · Cited by 23
Not Again: Benzodiazepines Once More Under Attack
Salzman, C., & Shader, R. I. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000383 · Cited by 11
Buysse, D. J., & Reynolds, C. F. (2000) · Sage eBooks · doi:10.4135/9781452225555.n10 · Cited by 11
Gonzalez-Salvador (1999) · doi:10.1002/(sici)1099-1166(199909)14:9
Cited by
Polypharmacy Management in Older Patients
Hoel, R. W., Giddings Connolly, R. M., & Takahashi, P. Y. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.06.012 · Cited by 196
Sawan, M. J., Reeve, E., Turner, J. P., Todd, A., Steinman, M. A., Petrović, M., & Gnjidic, D. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1730812 · Cited by 142
Self-citationNg, B. J., Le Couteur, D. G., & Hilmer, S. N. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0544-4 · Cited by 118
Reeve, E., Moriarty, F., Nahas, R., Turner, J. P., O’Donnell, L. K., & Hilmer, S. N. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1397625 · Cited by 100
“Systematic reviews have described the ability to withdraw benzodiazepine use in approximately 25– 85% of older adult users without return of condition (often with tapering regimens to minimize ADWEs) [39,42].”
BackgroundSelf-citationNguyen, V. V., George, T., & Brewster, G. S. (2019) · Current Geriatrics Reports · doi:10.1007/s13670-019-00300-x · Cited by 89
Metadata
- Authors
- Reeve, E., Ong, M., Wu, A., Jansen, J., Petrovic, M., & Gnjidic, D.
- Affiliations
- The University of Sydney (AU)
- Corresponding author
- Reeve, Emily
- Venue
- European Journal of Clinical Pharmacology
- Published
- 2017-04-30
- Volume
- 73
- Issue
- 8
- Pages
- 927-935
- ISSN
- 0031-6970 (ISSN-L)
- 1432-1041
- OpenAlex
- W2610021354
- Cited by
- 192
- References
- 45
- Citations by year
- 2026: 16 · 2025: 26 · 2024: 25 · 2023: 25 · 2022: 19 · 2021: 24 · 2020: 17 · 2019: 20 · 2018: 17 · 2017: 3
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- Locations
- European Journal of Clinical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- benzodiazepine deprescribing, Z-drugs, hypnotics, older adults, benzodiazepine withdrawal, benzodiazepine tapering, patient education, sleep quality, quality of life, adverse drug reactions
- MeSH terms
- Deprescriptions, Aged, Benzodiazepines, Humans, Hypnotics and Sedatives, Sleep Initiation and Maintenance Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.